Logo image of PRE.MI

PREDICT SPA (PRE.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:PRE - IT0005611071 - Common Stock

0.82 EUR
-0.04 (-4.65%)
Last: 11/17/2025, 7:00:00 PM
Fundamental Rating

4

PRE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 27 industry peers in the Health Care Providers & Services industry. PRE has an excellent financial health rating, but there are some minor concerns on its profitability. PRE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year PRE was profitable.
PRE.MI Yearly Net Income VS EBIT VS OCF VS FCFPRE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 500K -500K 1M -1M

1.2 Ratios

PRE has a better Return On Assets (7.11%) than 88.89% of its industry peers.
The Return On Equity of PRE (16.48%) is better than 77.78% of its industry peers.
PRE has a better Return On Invested Capital (14.60%) than 96.30% of its industry peers.
Industry RankSector Rank
ROA 7.11%
ROE 16.48%
ROIC 14.6%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PRE.MI Yearly ROA, ROE, ROICPRE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2 4 6

1.3 Margins

PRE has a Profit Margin of 5.07%. This is amongst the best in the industry. PRE outperforms 88.89% of its industry peers.
PRE's Operating Margin of 7.76% is in line compared to the rest of the industry. PRE outperforms 59.26% of its industry peers.
The Gross Margin of PRE (20.96%) is comparable to the rest of the industry.
Industry RankSector Rank
OM 7.76%
PM (TTM) 5.07%
GM 20.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PRE.MI Yearly Profit, Operating, Gross MarginsPRE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 5 10 15 20

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so PRE is creating value.
PRE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PRE.MI Yearly Shares OutstandingPRE.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 1M 2M 3M 4M 5M
PRE.MI Yearly Total Debt VS Total AssetsPRE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2M 4M 6M

2.2 Solvency

PRE has an Altman-Z score of 3.52. This indicates that PRE is financially healthy and has little risk of bankruptcy at the moment.
PRE's Altman-Z score of 3.52 is amongst the best of the industry. PRE outperforms 92.59% of its industry peers.
PRE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.52
ROIC/WACC1.91
WACC7.64%
PRE.MI Yearly LT Debt VS Equity VS FCFPRE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 1M -1M 2M

2.3 Liquidity

A Current Ratio of 1.27 indicates that PRE should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.27, PRE is in line with its industry, outperforming 59.26% of the companies in the same industry.
A Quick Ratio of 0.90 indicates that PRE may have some problems paying its short term obligations.
PRE has a Quick ratio (0.90) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.9
PRE.MI Yearly Current Assets VS Current LiabilitesPRE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

1

3. Growth

3.1 Past

PRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.14%, which is quite impressive.
The Revenue has decreased by -7.84% in the past year.
EPS 1Y (TTM)76.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1757.14%
Revenue 1Y (TTM)-7.84%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-46.31%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PRE.MI Yearly Revenue VS EstimatesPRE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2M 4M 6M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.67, which indicates a correct valuation of PRE.
81.48% of the companies in the same industry are more expensive than PRE, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.15. PRE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 13.67
Fwd PE N/A
PRE.MI Price Earnings VS Forward Price EarningsPRE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PRE.MI Per share dataPRE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PREDICT SPA

BIT:PRE (11/17/2025, 7:00:00 PM)

0.82

-0.04 (-4.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.57M
Revenue(TTM)6.63M
Net Income(TTM)336.00K
Analysts80
Price Target1.94 (136.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.67
Fwd PE N/A
P/S 0.69
P/FCF N/A
P/OCF N/A
P/B 2.24
P/tB 2.83
EV/EBITDA N/A
EPS(TTM)0.06
EY7.32%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.19
BVpS0.37
TBVpS0.29
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.7
Profitability
Industry RankSector Rank
ROA 7.11%
ROE 16.48%
ROCE 21.65%
ROIC 14.6%
ROICexc 16.05%
ROICexgc 19.99%
OM 7.76%
PM (TTM) 5.07%
GM 20.96%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.4
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 0.9
Altman-Z 3.52
F-ScoreN/A
WACC7.64%
ROIC/WACC1.91
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1757.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.84%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-46.31%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y56.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

PREDICT SPA / PRE.MI FAQ

What is the ChartMill fundamental rating of PREDICT SPA (PRE.MI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to PRE.MI.


Can you provide the valuation status for PREDICT SPA?

ChartMill assigns a valuation rating of 2 / 10 to PREDICT SPA (PRE.MI). This can be considered as Overvalued.


Can you provide the profitability details for PREDICT SPA?

PREDICT SPA (PRE.MI) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for PRE stock?

The Price/Earnings (PE) ratio for PREDICT SPA (PRE.MI) is 13.67 and the Price/Book (PB) ratio is 2.24.


Can you provide the financial health for PRE stock?

The financial health rating of PREDICT SPA (PRE.MI) is 7 / 10.